ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro, Inc.

In a report released today, Frank Takkinen from Lake Street maintained a Buy rating on ClearPoint Neuro, with a price target of $30.00. According t...

Lake Street Remains a Buy on ClearPoint Neuro (CLPT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Delcath Systems (DCTH – Research Report) and ClearPo...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLPT	$12.71	-2.00%	607.00K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLPT	$12.71	-2.0%	607.00K
3
4
5
6

CLPT

CLPT

Dividend Overview

Get ClearPoint Neuro, Inc. Data in Excel

Get ClearPoint Neuro, Inc. Data in Excel